WOCKHARDT
|
The Current P/S Ratio of WOCKHARDT is 7.76.
| Share Price | ₹1,611.3 | May 20,2026 |
| Market Cap | ₹26,183.6 Cr | |
| Sales-TTM | ₹3,373.0 Cr | TTM-Consolidated Results |
| Price/Sales | 7.76x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WOCKHARDT
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹26,183.6 Cr] as on May 20,2026
(/) Sales [ ₹3,373.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.76x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '7.76 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WOCKHARDT !
The chart below summarizes the trend in P/S Ratio of WOCKHARDT over the last five years.
Historical PS (Price/Sales) ratio chart of WOCKHARDT
PS Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.91x.
- WOCKHARDT 's operated at median p/e ratio of 1.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2025 at 7.66x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2023 of 0.84x.
How does WOCKHARDT 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WOCKHARDT | 3,373.0 | 7.76 | 26,183.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.94 | 451,195.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 17.74 | 182,993.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.77 | 149,926.0 |
| CIPLA LTD | 28,162.6 | 4.01 | 113,052.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.27 | 110,333.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.47 | 106,669.0 |
| LUPIN LTD | 27,958.0 | 3.73 | 104,401.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.86 | 104,744.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.63 | 87,336.6 |
| LAURUS LABS LTD | 6,812.9 | 10.79 | 73,490.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WOCKHARDT 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.63x |
| Max industry PS | 17.74x |
| Median industry PS | 7.47x |
| Average industry PS | 7.36x |
You may also like the below Video Courses